Literature DB >> 10080140

The role of phospholipase A2 in calcium-ionophore-mediated injury to rat gastric mucosal cells.

B L Tepperman1, B D Soper.   

Abstract

Although transient increases in intracellular Ca2+ ([Ca2+]i) underlie a number of important physiological processes, sustained elevations in [Ca2+]i mediate damage to a number of tissues and cell types including gastric mucosal cells. Increases in [Ca2+]i can activate phospholipid hydrolysis via increases in phospholipase A2 (PLA2) activity and subsequent cell injury. In the present study we have examined whether [Ca2+]i-induced gastric cellular injury is mediated by PLA2 activation. Gastric mucosal cells were harvested from rat stomachs after pronase digestion. Cell integrity was assessed using trypan blue dye exclusion and release of lysozomal enzymes. PLA2 activity was estimated colorimetrically by determination of thiol release from the substrate, arachidonyl thio-PC. In these studies calcium ionophore A23187 (3-25 microM) resulted in an increase in cell injury. The damage produced by A23187 (12.5 microM) was inhibited by preincubation of cells with the PLA2 inhibitor, quinacrine (1-100 microM). Quinacrine did not reduce ethanol (10% w/v) mediated-cell damage. Similarly Ca2+ ionophore A23187 treatment resulted in a concentration-dependent increase in PLA2 activity in gastric cells. The increase in PLA2 activity was attenuated if cells were incubated in Ca2+-depleted medium containing EGTA (4 mM). Furthermore lysophospholipids generated by PLA2 (lysophosphatidylethanolamine and lysophosphatidylcholine; 100 microM) also increased the degree of cell injury. Pretreatment of cells with the PAF antagonist WEB 2086 (10(-6) and 10(-5) M), the leukotriene synthase inhibitor 5,6-dehydroarachidonic acid (10 microM), or the thromboxane synthase inhibitor furegrelate (1 microM) decrease A23187-mediated cell injury. These data suggest that Ca2+ ionophore-mediated increases in [Ca2+]i result in gastric cell injury and this effect is mediated in part by PLA2 activation and subsequent release of free fatty acids and lysophosphatides.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10080140     DOI: 10.1023/a:1026688819939

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  36 in total

1.  Effect of extracellular Ca2+ on indomethacin-induced injury to rabbit dispersed gastric mucosal cells.

Authors:  B L Tepperman; B D Soper
Journal:  Can J Physiol Pharmacol       Date:  1994-01       Impact factor: 2.273

2.  Eicosanoid production by the human gastric cancer cell line AGS and its relation to cell growth.

Authors:  S Shimakura; C R Boland
Journal:  Cancer Res       Date:  1992-04-01       Impact factor: 12.701

3.  Role of phospholipase A2 and oxygenated free radicals in mucosal damage after small intestinal ischemia and reperfusion.

Authors:  T Otamiri; C Tagesson
Journal:  Am J Surg       Date:  1989-06       Impact factor: 2.565

4.  The proinflammatory effect of intra-articular injection of soluble human and venom phospholipase A2.

Authors:  P Vadas; W Pruzanski; J Kim; V Fornasier
Journal:  Am J Pathol       Date:  1989-04       Impact factor: 4.307

5.  Eosinophil cationic protein and phospholipase A2 activity in human gastric juice. With emphasis on Helicobacter pylori status and effects of antacids.

Authors:  K Berstad; A Berstad; R Sjödahl; R Weberg; A Berstad
Journal:  Scand J Gastroenterol       Date:  1992-12       Impact factor: 2.423

6.  Reperfusion mucosal damage after complete intestinal ischemia in the dog: the effects of antioxidant and phospholipase A2 inhibitor therapy.

Authors:  M Boros; G Karácsony; J Kaszaki; S Nagy
Journal:  Surgery       Date:  1993-02       Impact factor: 3.982

7.  Reduced glutathione modulates Ca(2+)-mediated damage to rabbit isolated gastric mucosal cells.

Authors:  H M Wong; B L Tepperman
Journal:  Am J Physiol       Date:  1994-07

8.  Phospholipase A2 activation in cultured mouse hepatocytes exposed to tumor necrosis factor-alpha.

Authors:  G M Adamson; T J Carlson; R E Billings
Journal:  J Biochem Toxicol       Date:  1994-08

9.  PAF formation by human gastrointestinal mucosa/submucosa in-vitro: release by ricinoleic acid, and inhibition by 5-aminosalicylic acid.

Authors:  F Capasso; I A Tavares; A Bennett
Journal:  J Pharm Pharmacol       Date:  1992-09       Impact factor: 3.765

10.  Lysophosphatidylcholine causes Ca2+ influx, enhanced DNA synthesis and cytotoxicity in cultured vascular smooth muscle cells.

Authors:  Y Chen; S Morimoto; S Kitano; E Koh; K Fukuo; B Jiang; S Chen; O Yasuda; A Hirotani; T Ogihara
Journal:  Atherosclerosis       Date:  1995-01-06       Impact factor: 5.162

View more
  3 in total

1.  A direct role for secretory phospholipase A2 and lysophosphatidylcholine in the mediation of LPS-induced gastric injury.

Authors:  Elizabeth J Dial; Duy M Tran; Jimmy J Romero; Mayssa Zayat; Lenard M Lichtenberger
Journal:  Shock       Date:  2010-06       Impact factor: 3.454

2.  Metabolomic Profiling of Plasma from Melioidosis Patients Using UHPLC-QTOF MS Reveals Novel Biomarkers for Diagnosis.

Authors:  Susanna K P Lau; Kim-Chung Lee; George C S Lo; Vanessa S Y Ding; Wang-Ngai Chow; Tony Y H Ke; Shirly O T Curreem; Kelvin K W To; Deborah T Y Ho; Siddharth Sridhar; Sally C Y Wong; Jasper F W Chan; Ivan F N Hung; Kong-Hung Sze; Ching-Wan Lam; Kwok-Yung Yuen; Patrick C Y Woo
Journal:  Int J Mol Sci       Date:  2016-02-27       Impact factor: 5.923

3.  Metabolomics coupled with pathway analysis characterizes metabolic changes in response to BDE-3 induced reproductive toxicity in mice.

Authors:  Ziheng Wei; Jing Xi; Songyan Gao; Xinyue You; Na Li; Yiyi Cao; Liupeng Wang; Yang Luan; Xin Dong
Journal:  Sci Rep       Date:  2018-04-03       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.